Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Shaheed Beheshti Medical University.
Recruitment status was  Recruiting
Study NCT01178697   Information provided by Shaheed Beheshti Medical University

First Received on August 2, 2010.   Last Updated on August 9, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Central Retinal Vein Occlusion
Additional conditions recognized in this trial
Retinal Vein Occlusion
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Eye Diseases
Retinal Diseases
Thrombosis
Vascular Diseases
Venous Thrombosis
Interventions listed in this trial
Bevasizumab
Triamcinolone Acetonide
Additional drug interventions recognized in this trial
Triamcinolone
Triamcinolone diacetate
Triamcinolone hexacetonide
More general drug interventions related to this trial
Anti-Inflammatory Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Shaheed Beheshti Medical University
Ophthalmic Research Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services